This bill amends the laws regulating the testing of adult use cannabis and adult use cannabis products as follows.
1. It provides that testing rules adopted by the Department of Administrative and Financial Services, Office of Cannabis Policy must establish a testing limit for total yeast and mold contamination in adult use cannabis and adult use cannabis products of 100,000 colony-forming units per gram and may require other microbial testing only for microbes harmful to human health, as determined by the office, including, but not limited to, Escherichia coli, salmonella and coliform bacteria.
2. It establishes a process by which an adult use cannabis licensee may become eligible for audit testing of the licensee's adult use cannabis or adult use cannabis products by conducting 10 consecutive and separate mandatory tests of different batches of the cannabis or cannabis products, if the results of each of those tests demonstrate that the batch of cannabis or cannabis products do not exceed the maximum level of allowable contamination for any contaminant that is injurious to health and for which testing is required. If determined eligible for audit testing by the office, the licensee is not required to test the licensee's adult use cannabis or adult use cannabis products prior to sale or distribution to a consumer unless the licensee fails an audit test.
3. It requires testing facilities to submit to the office the results of all testing conducted for adult use cannabis licensees, regardless of whether a licensee's adult use cannabis or adult use cannabis product tested exceeds the maximum level of allowable contamination for any contaminant that is injurious to health and for which testing is required. It also requires the office to make available on its publicly accessible website all mandatory testing results submitted by testing facilities, regardless of whether the cannabis or cannabis product passed or failed the test. The office must anonymize the testing results so that the licensee for which the test was conducted is indicated only through a unique identifying number or other anonymous indicator assigned by the office. Testing results must be made available on its publicly accessible website on a quarterly basis, no earlier than 3 months after the date on which the testing was conducted.